und will dann ab dem zweiten Quartal 2022 seinen inaktivierten Impfstoff (Grundlage: Originalvirus Wuhan) mit gentechnischem Wirkverstärker ausliefern....
Valneva now expects recommendation on COVID-19 vaccine by April | Reuters
Valneva now expects a positive recommendation from the European Medicines Agency (EMA) in April for its VLA2001 COVID-19 candidate vaccine, the French vaccine maker said on Friday, compared to an earlier target for the end of March.